Press "Enter" to skip to content

New patent expiration for Allergan drug OZURDEX

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for Allergan drug OZURDEX

Annual Drug Patent Expirations for OZURDEX
Annual Drug Patent Expirations for OZURDEX

Ozurdex is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are seventeen patents protecting this drug.

This drug has one hundred and thirty-nine patent family members in twenty-seven countries.

The generic ingredient in OZURDEX is dexamethasone. One supplier is listed for this compound. Additional details are available on the dexamethasone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Allergan drug OZURDEX

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!